Powsali Ghosh

Powsali Ghosh

Pharmaceutical Engineering & Technology, Indian Institute of Technology BHU, Vārānasi, Uttar Pradesh, International
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Neurochemistry International
Verified
Journal Article
Closed access
Powsali GhoshPowsali Ghosh
Powsali Ghosh
RSRavi Singh
Ravi Singh
AGAnkit Ganeshpurkar
Ankit Ganeshpurkar
APAnkit Vyankatrao Pokle
Ankit Vyankatrao Pokle
RSRavi Bhushan Singh
Ravi Bhushan Singh
AKAshok Kumar
Ashok Kumar

30 September 2021 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
RSRavi Singh
Ravi Singh
AGAnkit Ganeshpurkar
Ankit Ganeshpurkar
Powsali GhoshPowsali Ghosh
Powsali Ghosh
APAnkit Vyankatrao Pokle
Ankit Vyankatrao Pokle
DKDevendra Kumar
Devendra Kumar
AKAshok Kumar
Ashok Kumar

1 October 2022 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
SSSushil Kumar Singh
Sushil Kumar Singh
AKAshok Kumar
Ashok Kumar
RSRavi Bhushan Singh
Ravi Bhushan Singh
Powsali GhoshPowsali Ghosh
Powsali Ghosh
NBNilesh Gajanan Bajad
Nilesh Gajanan Bajad
Alzheimer's disease (AD) is a complex multifactorial neurodegenerative disease characterized by progressive memory loss. The main pathological features of the disease are extracellular deposition of amyloid β (Aβ) plaques and intracellular neurofibrillary tangles composed of hyper-phosphorylated tau protein. The understanding of factors contributing to AD progression, number of molecular signatures, and the development of therapeutic agents played a significant role in the discovery of disease-modifying drugs to treat the disease. Bioinformatics has established its significance in many areas of biology. The role of bioinformatics, in drug discovery is emerging significantly and will continue to evolve. In recent years, different bioinformatics methodologies, viz. protein signaling pathway, molecular signature differences between different classes drugs, interacting profiles of drugs and their potential therapeutic mechanisms have been applied to identify potential therapeutic targets of AD. Bioinformatics tools were also found to contribute in the discovery of novel drugs, omics-based biomarkers, and drug repurposing for AD. The review aims to explore the applications of various advanced bioinformatics tools in the identification of targets, biomarkers, pathways, and potential therapeutics for the treatment of the disease.

21 July 2022 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
RSRavi Singh
Ravi Singh
APAnkit Vyankatrao Pokle
Ankit Vyankatrao Pokle
Powsali GhoshPowsali Ghosh
Powsali Ghosh
AGAnkit Ganeshpurkar
Ankit Ganeshpurkar
RSRayala Swetha
Rayala Swetha
AKAshok Kumar
Ashok Kumar
LIM kinases (LIMKs) are a family of protein kinases involved in the regulation of actin dynamics. There are two isoforms of LIMKs i.e., LIMK1 and LIMK2. LIMK1 is expressed abundantly in neuronal tissues. LIMK1 plays an essential role in the degradation of dendritic spines, which are important for our higher brain functions, such as memory and learning. The inhibition of LIMK1 improves the size and density of dendritic spines and acts as a protective effect against Alzheimer's disease. In this study, we have adopted ligand-based drug design and molecular modelling methods to identify virtual hits. The pharmacophoric features of PF-00477736 were used to screen the Zinc15 compounds library. The identified hits were then passed through drug-likeliness and PAINS filters. Further, comprehensive docking and rigorous molecular dynamics simulation study afforded three virtual hits viz., ZINC504485634, ZINC16940431 and ZINC1091071. The hits showed a better docking score than the standard ligand, PF-00477736. The docking score was found to be –8.85, –7.50 and –7.68 kcal/mol. These hits exhibited optimal binding properties with the target in docking study, blood-brain barrier permeability, in silico pharmacokinetics and low predicted toxicity. Communicated by Ramaswamy H. Sarma Graphical Abstract

21 December 2022 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
Powsali GhoshPowsali Ghosh
Powsali Ghosh
RSRavi Singh
Ravi Singh
AGAnkit Ganeshpurkar
Ankit Ganeshpurkar
RSRayala Swetha
Rayala Swetha
DKDevendra Kumar
Devendra Kumar
AKAshok Kumar
Ashok Kumar

11 January 2025 in Journal of Computational Chemistry
Verified
Journal Article
Closed access
Powsali GhoshPowsali Ghosh
Powsali Ghosh
AKAshok Kumar
Ashok Kumar
SSSingh Kumar Singh
Singh Kumar Singh